CHAPTER 1. Industry Overview of Orthobiologics
1.1. Definition and Scope
1.1.1. Definition of Orthobiologics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Orthobiologics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Orthobiologics Market By Product
1.2.3. Orthobiologics Market By Application
1.2.4. Orthobiologics Market By End User
1.2.5. Orthobiologics Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Orthobiologics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Orthobiologics Market
3.7. Value Chain Analysis
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Orthobiologics Market By Product
4.1. Introduction
4.2. Orthobiologics Revenue By Product
4.2.1. Orthobiologics Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Demineralized Bone Matrix (DBM)
4.2.2.1. Demineralized Bone Matrix (DBM) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Allograft
4.2.3.1. Allograft Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Bone Morphogenetic Protein (BMP)
4.2.4.1. Bone Morphogenetic Protein (BMP) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Viscosupplementation Products
4.2.5.1. Viscosupplementation Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Synthetic Bone Substitutes
4.2.6.1. Synthetic Bone Substitutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Others
4.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Orthobiologics Market Revenue By Application
5.1. Introduction
5.2. Orthobiologics Revenue (US$ Mn) By Application
5.2.1. Orthobiologics Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Osteoarthritis and Degenerative Arthritis
5.2.2.1. Osteoarthritis and Degenerative Arthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Spinal Fusion
5.2.3.1. Spinal Fusion Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Fracture Recovery
5.2.4.1. Fracture Recovery Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Soft Tissue Injuries
5.2.5.1. Soft Tissue Injuries Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Maxillofacial and Dental Applications
5.2.6.1. Maxillofacial and Dental Applications Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Orthobiologics Market By End User
6.1. Introduction
6.2. Orthobiologics Revenue (US$ Mn) By End User
6.2.1. Orthobiologics Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
6.2.2. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
6.2.2.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Research and Academic Institutes
6.2.3.1. Research and Academic Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Dental Clinics and Facilities
6.2.4.1. Dental Clinics and Facilities Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Orthobiologics Market By Country
7.1. North America Orthobiologics Overview
7.2. U.S.
7.2.1. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.2.3. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.3. Canada
7.3.1. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3.3. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Orthobiologics Market By Country
8.1. Europe Orthobiologics Market Overview
8.2. U.K.
8.2.1. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Germany
8.3.1. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. France
8.4.1. France Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4.3. France Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.5. Spain
8.5.1. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5.3. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6.3. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Orthobiologics Market By Country
9.1. Asia Pacific Orthobiologics Market Overview
9.2. China
9.2.1. China Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2. China Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.2.3. China Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.3. Japan
9.3.1. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3.3. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.4. India
9.4.1. India Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2. India Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4.3. India Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.5. Australia
9.5.1. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5.3. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6.3. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.7.2. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.7.3. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Orthobiologics Market By Country
10.1. Latin America Orthobiologics Market Overview
10.2. Brazil
10.2.1. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.3. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.3. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.2. Rest of Latin America Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 11. Middle East & Africa Orthobiologics Market By Country
11.1. Middle East & Africa Orthobiologics Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.3. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. UAE
11.3.1. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.3. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.3. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
CHAPTER 12. Player Analysis Of Orthobiologics
12.1. Orthobiologics Market Company Share Analysis
12.2. Mergers And Acquisition In Global Orthobiologics Market
CHAPTER 13. Company Profile
13.1. Arthrex, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Arthrex, Inc. 2019 Orthobiologics Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Manufacturing Plant Footprint Analysis
13.2. Exactec Inc.
13.3. Globus Medical, Inc.
13.4. Integra LifeSciences Holdings Corporation
13.5. Johnson and Johnson
13.6. Medline Industries, Inc.
13.7. NuVasive Inc.
13.8. Stryker Corporation
13.9. Wright Medical Group, Inc.
13.10. Zimmer Biomet Holdings, Inc.
13.11. Others
The market for orthobiologics is expected to reach a market value of around US$ 7,725.6 Mn by 2027.
The orthobiologics market is expected to grow at a CAGR of around 5.6% from 2020 to 2027.
The viscosupplementation product is the leading segment by product in the orthobiologics market.
The increasing incidence of sports injuries & road accidents, increasing incidence of spinal diseases/disorders, rising geriatric & obese population, and growing patient preference for minimally invasive procedures are some of the prominent factors driving the market growth.
Arthrex, Inc. (Arthrex), Exactec Inc., Globus Medical, Inc., Integra LifeSciences Holdings Corporation, Johnson and Johnson (J&J), Medline Industries, Inc., NuVasive Inc., Stryker Corporation, Wright Medical Group, Inc., and Zimmer Biomet Holdings, Inc. are the prominent players in the market.
North America held the highest market share in the orthobiologics market.
Asia Pacific is expected to be the fastest growing market over the forecast period.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date